A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

Health ministry has issued statement highlighting that extensive studies by ICMR and AIIMS, New Delhi have established there ...

Indian pharmaceutical industry defends Covid-19 vaccines amid concerns, emphasizing global standards, safety, and efficacy to ...

Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we ...

With clinical trials under pressure, industry leaders say it’s time for reform, digital transformation, and more patient-centric models.

The global lipid nanoparticles (LNP) contract development and manufacturing organization (CDMO) market is poised for substantial double-digit growth by 2027, driven by the growing acceptance of LNPs ...

Nearly two-thirds of MS patients showed no signs of disability progression five years after having a stem cell transplant, a ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Nicotine vaping continues to outperform FDA-approved smoking cessation therapies in well-designed studies, including a new clinical trial conducted in Australia. This growing body of evidence badly ...